Skip to main content

Table 4 Antibiograms of multi-drug resistanta MRSA from inpatients and outpatientsb

From: Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

  Inpatient (n = 6,183) Outpatient (n = 1,757)
Agents n (%) Susceptible n (%) Susceptible
Ciprofloxacin 7 (0.1) 5 (0.3)
Erythromycin 20 (0.3) 13 (0.7)
Clindamycin 85 (1.4) 38 (2.2)
Gentamicin 4,971 (80.4) 1,430 (81.4)
Trimethoprim-sulfamethoxazole 5,814 (94.0) 1,657 (94.3)
Linezolid 6,180 (>99.9) 1,757 (100)
Vancomycin 6,183 (100.0) 1,757 (100)
  1. aMultiple-drug resistance: resistance to three or more of the following agents: ciprofloxacin, erythromycin, clindamycin, gentamicin, trimethoprim/sulfamethoxazole, linezolid, and vancomycin
  2. bCumulative data 1998 – 2005 YTD